Skip to main content
Molecules logoLink to Molecules
. 2012 Oct 24;17(11):12521–12532. doi: 10.3390/molecules171112521

Antioxidant, Lipoxygenase and Histone Deacetylase Inhibitory Activities of Acridocarbus orientalis From Al Ain and Oman

Taoufik Ksiksi 1,*, Alaaeldin A Hamza 1,2
PMCID: PMC6268325  PMID: 23095895

Abstract

Acridocarpus orientalis (AO) is a traditional medicinal plant used for treatment of inflammatory diseases that may have potential in cancer treatment. In the present study, the aqueous ethanolic crude extract of Acridocarpus aerial parts obtained from Al Ain and Oman were evaluated for their antioxidant capability, polyphenolic content, anti-lipoxygenase and anti-histone deacetylase (HDAC) properties. The total antioxidant capacity was estimated by the FRAP, DPPH, ABTS and β-carotene bleaching assays. Acridocarpus-Al Ain exhibited the highest polyphenolic content (184.24 mg gallic acid/g) and the best antioxidant activity (1.1, 1.04, 1.14 mmol ascorbic acid equivalent/g in the FRAP, ABTS and DPPH assays, respectively). Additionally, the same extract showed significant anti-inflammatory properties via lipoxygenase (LOX) inhibitory activity (IC50 = 50.58 µg/mL). Acridocarpus-Al Ain also showed the strongest histone deacetylase (HDACs) inhibitory activity (IC50 = 93.28 µg/mL). The results reported here suggest that there was a significant influence of location and the plant may be considered a good source of compounds with antioxidant, anti-LOX and HDAC properties for therapeutic, nutraceutical and functional food applications.

Keywords: Acridocarpus orientalis, total phenol, antioxidant, anti-lipoxygenase, anti-histone deacetylase activity

1. Introduction

Many plant species represent a large source of structurally new compounds that might serve as leads for the development of new drugs, nutraceuticals and functional foods. Much of the therapeutic activity of plants is due to their biologically active polyphenolic substances, mostly flavonoids and phenolic acids, which possess antioxidant, anti-lipoxygenase and anticancer activities [1,2]. In developing countries and particularly the Gulf Countries, large segments of the population still rely on folk medicine to treat serious diseases including cancers and various types of inflammations.

Reactive oxygen species (ROS) induce oxidative damage to biomolecules like lipids, nucleic acids, proteins and carbohydrates. This damage causes the onset of many diseases such as rheumatoid arthritis, cirrhosis, arteriosclerosis, diabetes and cancer [3]. ROS also affect food quality. Interest in finding naturally occurring antioxidants for use in food preservation, flavoring, cosmetics, and in health promotion to replace synthetic antioxidants, that are being restricted due to their carcinogenicity [2] has increased noticeably. In addition, ROS propagate inflammation by stimulating release of cytokines and activation of enzymes such as lipoxygenases (LOXs) from inflammatory cells. LOXs are the key enzymes in the biosynthesis of leukotrienes from fatty acids producing active lipid metabolites. LOX is involved in provoking several inflammation-related diseases such as arthritis, asthma, cardiovascular, cancer and allergic diseases [4,5]. For this reason, targeting inhibitors of LOX is a promising therapeutic target for treating wide spectrum of human diseases.

Histone deacetylases (HDACs) are becoming a prominent therapeutic target for treatment of cancer and other diseases [6]. HDAC inhibitors (HDACI) represent a novel class of targeted drugs which alter the acetylation statues of several proteins. These agents, modulating both chromatin structure through histone acetylation, and the activity of several non-histone substrates, are able to determine changes in gene transcription and to induce a plethora of biological effects ranging from cell death induction, to angiogenesis inhibition or modulation of immune responses [7]. The shortcomings of HDACs are instability and toxicity [8,9]. For this reason, targeting natural inhibitors of HDAC is a promising therapeutic target for treating a wide spectrum of human diseases

Acridocarpus orientalis (AO), belonging to the Malpighiaceae family, is widespread in tropical Africa, Asia and the Mediterranean region and in the sandy plains in the Western Gulf countries. Currently, it is being cultivated in the greenhouse and under laboratory conditions [10]. Acridocarpus socotranus is commonly traditionally used in Yemen for the treatment of headaches and muscle pain [11,12]. The leaves and bark of Acridocarpus chloropterus in Tanzania have been reported to have antiplasmodial, anti-trypanosomal and anti-leishmanial activities [13]. Several species of Acridocarpus are still used traditionally all over the World as folk medicines, and more specific research to justify this is essential.

Based on the above rationale, the objective of this research focused on the quantitative determination of the phenolic content, antioxidant, anti-lipoxygenase and anti-HDAC activities of the aqueous ethanol extract of AO obtained from Al Ain and Oman. The antioxidant potential of AO was assessed in comparison with the scavenging power of the two stable nitrogen–centered radicals, 1,1-diphenyl-2-picrylhydrazyl (DPPH•) and 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) radical (ABTS•+). The reducing power of antioxidants was assessed by the ferric reducing antioxidant power (FRAP) assay as well as anti-bleaching of β-carotene activity. LOX inhibitory activity of Acridocarpus extracts was also measured. Finally, HDAC inhibition activity of Acridocarpus extracts was measured with a HDAC Colorimetric Assay Kit (Millipore Corporation).

2. Results and Discussion

2.1. Antioxidant, Free Radical Scavenging Activity

One single method cannot precisely assess the antioxidant capacities of plant extracts due to the complex nature of the different phytochemical classes present in plants. In the present work, the FRAP, ABTS, DPPH• and β-carotene assays were used to test the antioxidant activities of Acridocarpus orientalis extracts. The results of the four assays are summarized in Table 1.

Table 1.

Total antioxidant activity of ethanol extract from Acridocarpus orientalis expressed as ascorbic acid equivalents (mmol/g of dry extract). Trolox was used as positive control.

Extract FRAP Assay ABTS Assay DPPH Assay β-Carotene Assay
TAC (mmol/g) TAC (mmol/g) IC50 (µg/mL) TAC (mmol/g) IC50 (µg/mL) IC50 (µg/mL)
Acridocarpus-Al Ain (a) 1.10 ± 0.01 1.04 ± 0.02 58.06 ± 1.39 b,c 1.14 ± 0.01 29.84 ± 0.59 b,c 5.0 ± 0.04 b,c
Acridocarpus-Oman (b) 0.96 ± 0.02 0.98 ± 0.01 72.32 ± 1.61 a,c 1.04 ± 0.36 32.44 ± 0.34 a,c 6.32 ± 0.04 a,c
Trolox (c) 3.86 ± 0.09 a,b 1.83 ± 0.45 33.58 ± 1.43 a,b 3.99 ± 0.03 10.07 ± 0.09 a,b 3.03 ± 0.04 a,b

Values are means ± SE of three experiments. Data with on letters are significantly different (p < 0.05).

2.1.1. FRAP Assay

FRAP assay depends on reduction of oxidized ferric ions to ferrous ions by antioxidant agents. Table 1 shows that all extracts exhibited some degree of electron donation capacity. Extract of Acridocarpus-Al Ain exhibited the highest antioxidant potency (1.10 mmol ascorbic acid equivalent/g). The antioxidant potency of in FRAP assay was in the following order Trolox (3.86 mmol/g) > Acridocarpus-Al Ain extract (1.10 mmol/g) > Acridocarpus-Oman extract (0.96 mmol/g). The FRAP values of Acridocarpus extracts were much higher than those values reported for other plants such as Leptadenia pyrotechnica Forssk (0.24 mmol/g) [14].

2.1.2. ABTS Radical Scavenging Assay

ABTS assay expressed as ascorbic acid equivalent/g dry extract varied from 1.83 mmol/g for Trolox to 0.98 mmol/g dry extract for Acridocarpus-Oman extract. In addition, the antioxidant activity evaluated as IC50 value (µg/mL) revealed a similar behavior. The best free radical scavenging activities are reflected by the smallest IC50 values. The percentage inhibition of ABTS radical scavenging ability of two Acridocarpus extracts was concentration dependent (Figure 1a). The Acridocarpus-Al Ain extract showed the strongest activity with IC50 = 58.06 µg/mL which was better than Acridocarpus-Oman extract with IC50 = 72.32 µg/mL. It is also important to note that the ABTS radical scavenging ability of Acridocarpus extracts was much greater than those values reported for peanuts (81.3 µmol/g) and pistachios (75.9 µmol/g) [15].

Figure 1.

Figure 1

(a) ABTS and (b) DPPH radical scavenging activities of Acridocarpus ethanol extracts and Trolox at various concentrations. Values are means ± SE of three experiments.

2.1.3. DPPH Radical Scavenging Assay

The DPPH radical- scavenging assay is a widely used method for evaluating the ability of plant extracts to scavenge free radical generated from DPPH reagent. DPPH, a stable free radical with purple color, changes into a stable yellow compound on reacting with an antioxidant. The DPPH radical is scavenged by antioxidants through donation of hydrogen radicals (H•) to form the stable DPPH-H molecule [16]. The results of the DPPH assay are shown in Table 1. The total antioxidant activity expressed as ascorbic acid equivalent/g dry extract varied from 3.99 mmol/g for Trolox to 1.04 mmol/g dry extract for Acridocarpus-Oman extract. In addition, the DPPH radical scavenging ability of samples evaluated as IC50 value (µg/mL). The best free radical scavenging activities (reflected by the smallest IC50 values) was exerted by Acridocarpus-Al Ain (IC50 = 29.84 µg/mL), which contained the highest amount of total phenolic. The lowest radical scavenging activity was exhibited by Acridocarpus-Oman extract (IC50 = 32.44 µg/mL). Scavenging abilities of the extracts were in the following order Trolox > Acridocarpus-Al Ain extract > Acridocarpus-Oman extract. The percentage inhibition DPPH radical scavenging ability of two Acridocarpus extracts was concentration dependent (Figure 1b). The DPPH radical-scavenging activity of Acridocarpus ethanol extracts was relatively greater than those reported for other plant species such as basil (IC50 = 500 µg/mL), sage (IC50 = 400 µg/mL) thyme (IC50 = 470 µg/mL), oregano (IC50 = 320 µg/mL), rosemary (IC50 = 180 µg/mL) and fennel (IC50 = 148 µg/mL) [17].

2.1.4. β-Carotene Bleaching Test

β-Carotene undergoes rapid bleaching in the absence of antioxidants. The presence of antioxidants hinders the extent of bleaching by neutralizing the linolic hydroperoxyl radical formed. The Trolox (IC50 = 3.03 µg/mL) and Acridocarpus-Al Ain extract (IC50 = 5.0) showed the highest ability to prevent bleaching of β-carotene, followed by Acridocarpus-Oman extract (IC50 = 6.32 µg/mL). The inhibition of bleaching of β-carotene capacity of Acridocarpus ethanol extract was substantially higher than those reported for mint and radish (IC50 > 100 µg/mL) [18] and chicory (IC50 > 100 µg/mL) [19]. These results led us to conclude that the antioxidant compounds extracted from Acridocarpus orientalis are more concentrated in Al Ain.

2.2. Total Phenolic Content

The total phenolic content of the medical plants extracts was measured with the Folin-Ciocalteu reagent assay and the results is shown in Table 2. The values varied from 184.24 to 149.23 mg gallic acid/g of dry extract. Acridocarpus-Al Ain exhibited the highest amount of total phenolics (184.24 mg gallic acid equivalent/g). Phytochemicals have been of great interest as a source of natural antioxidants used for health promotion, food preservation, food flavoring and cosmetics since they are safer for consumption and more environmentally friendly than their synthetic counterparts.

Table 2.

Total phenolic content of ethanol extract from Acridocarpus orientalis expressed as gallic acid equivalents (mg/g of dry extract).

Extract Yield (%) Total Phenolic Content * (mg/g)
Acridocarpus-Al Ain (a) 30% 184.24 ± 4.39 b
Acridocarpus-Oman (b) 22% 149.23 ± 2.84 a

* Values are means ± SE of three experiments. Data with on letters are significantly different (p < 0.05).

2.3. Correlation between Antioxidant Activity and Phenolic Contents

The linear correlation coefficients between the antioxidant capacity (measured by FRAP, DPPH, ABTS and β-carotene assays and total phenolic content of the four fractions are shown in Table 3. R2 values varied between 0.99 for β-carotene assay and 0.87 DPPH assays, which leads to believe that the presence of phenolic compounds contributes substantially to the antioxidant activity of the tested extracts, especially in the β-carotene assay. The above results are in agreement with previous reports that showed a liner correlation between the total phenolic content and the reducing antioxidant capacity of some plant extracts [16,20].

Table 3.

Linear correlations between the amount of total phenolic content and antioxidant activities of ethanol extract from Acridocarpus orientalis.

Assay Correlation (R2) Significance
FRAP activity 0.93 p < 0.01
ABTS• scavenging activity 0.94 p < 0.01
DPPH• scavenging activity 0.87 p < 0.01
β-Carotene bleaching inhibition 0.99 p < 0.001

2.4. LOX Inhibitory Assay

LOX catalyzes dioxygenation of polyunsaturated fatty acids to yield cis,trans-conjugated diene hydroperoxides. Results for LOX inhibitory activity (IC50) are shown in Figure 2. The Acridocarpus-Al Ain extract showed a strongest ability (p < 0.05) to inhibit LOX activity (IC50 = 50.58 µg/mL) in relation to the Acridocarpus-Oman extract (IC50 = 58.61 µg/mL). It is important to note that that both crude ethanol extracts possessed significantly lower (p < 0.05) LOX inhibitory activity than that of an NDGA positive standard (IC50 = 4.87 µg/mL). Finally, LOX inhibition of Acridocarpus orientalis extracts were higher than those for other common plants such as Thespesia lampas (600 µg/mL) [21]. The results reported here suggest that Acridocarpus orientalis has potentially high anti-LOX effect, which might be related to the polyphenolic content and antioxidant property of the extract.

Figure 2.

Figure 2

LOX inhibitory activity of Acridocarpus orientalis extracts expressed as IC50 (µg/mL). Values are means ± SE of three experiments.

2.5. HDAC Inhibitory Assay

HDAC inhibitors (HDACi) are becoming a prominent therapeutic target for treating a wide spectrum of human diseases, including cancer. HDAC inhibitors arrest cell growth and lead to apoptosis in tumor cells [6]. In previous studies, Cardiotoxicity, poor pharmacokinetic and non-selectivity were repeatedly reported for different HDACi and considered as the major drawback for the future development of synthetic HDACi [8,22]. For this reason, targeting natural inhibitors of HDAC is a promising therapeutic target for treating wide spectrum of human diseases. Curcumin, a phenolic compound isolated from turmeric, and sulforaphane, an isothiocyanate isolated from broccoli, have recently been identified to possess anticancer properties via HDACi activity [22,23]. In the present work, the ethanolic extract of Acridocarpus orientalis showed a high ability to inhibit HDAC activity (IC50 = 93.28 µg/mL) in Al Ain species in relation to the Oman plant extract (IC50 = 102.5 µg/mL) and this inhibitory effect was concentration dependent (Figure 3). This inhibitory effect of plant extract could be attributed to a direct ionic interaction of the active ingredients of plant with the active zinc site of HDAC enzyme where the classical HDACs are zinc-dependent enzymes bearing a highly conserved catalytic domain with a zinc ion [6].

Figure 3.

Figure 3

Concentration-response curve of HDAC inhibitory activity by Acridocarpus-Al Ain (IC50 = 93.28 µg/mL) and Acridocarpus-Oman (IC50 = 102.5 µg/mL).

3. Experimental

3.1. Chemicals

Ascorbic acid, ferric chloride, Folin-Ciocalteu reagent, dibutylhydroxytoluene (BHT), 2,4,6-tripyridyltriazine, gallic acid, sodium carbonate, 1,1-diphenyl-2-picrylhydrazyl (DPPH) and 2,4,6-tripyridyl triazine, 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) (ABTS), β-carotene (type I ≥ 93%) Trolox, soybean LOX and NDGA were obtained from Sigma Chemical Co. (St. Louis, MO, USA). HDAC colorimetric assay kit was purchased from Millipore Corporation (Temecula, CA, USA). All other chemicals were purchased from local commercial suppliers.

3.2. Plant Materials

Fresh Acridocarpus orientalis samples were collected from a dry river, on Jebel Hafeet mountain near Al Ain, UAE (N 24.19, E 55.62) and from Nizwa mountain in Oman (N22.9, E57.5). The collected samples were identified and representative specimens were deposited at the Biology Department Herbarium, Faculty of Science, UAE University.

3.3. Preparation of the Plant Extracts

An air-dried and ground aerial part sample of AO (10 g) was extracted with 70% (v/v) aqueous ethanol (200 mL). The mixture was macerated for 72 h at 4 °C. The resulting compound was then filter dried under reduced pressure in a rotary evaporator at 40 °C. An aqueous ethanol crude extract was generated. This crude extract was weighed, dissolved in 50% ethanol (typically 30 mg/mL) and kept at −20 °C for further analysis.

3.4. Total Phenolic Content Determination

Total phenolic content was assessed using the method reported by Singleton et al. [24] using the Folin-Ciocalteu reagent. For a typical plant extract, a sample of the residue obtained from the crude extract described in the section above (100 µL) was thoroughly mixed with the Folin-Ciocalteu reagent (200 µL) and de-ionized water (2 mL). An incubation period at room temperature for 3 min followed. After incubation, a sample of 20% aqueous sodium carbonate (w/w, 1 mL) was added to the mixture. After one hour of incubation at room temperature, the total polyphenols were determined by measuring the absorbance of the resulting substance at 765 nm with a PerkinElmer, Lambda 25 UV/VIS spectrophotometer. Values were expressed in milligrams of gallic acid equivalent per gram dry weight of plant species extract. Data presented here are averages of three replicates.

3.5. Estimation of Total Antioxidant Activity

3.5.1. FRAP assay

The reducing power of antioxidants by the decrease of the ferric ions to the ferrous ions constitutes the basis of the FRAP assay. A blue colored ferrous-tripyridyltriazine complex is formed, as per the method reported by Nenadis et al. [25]. The FRAP reagent was freshly prepared by mixing 2,4,6-tripyridyltriazine (10 mM, 1.0 mL) and ferric chloride (20 mM, 1.0 mL) in acetate buffer (0.25 M, 10 mL, pH 3.6). Samples of plant species extract (50 µL) were added to the FRAP reagent (3.0 mL). The tests were carried out in triplicates. After a period of 8 min incubation at room temperature, the absorbance was measured at 593 nm. A calibration curve of ascorbic acid was developed to quantitatively determine the antioxidant capacity of the plant extracts expressed as mmol ascorbic acid equivalent per gram of dry extract.

3.5.2. ABTS Assay

The reduction of the blue-green 2,2-azino-bis(3-ethylbenzothiazoline-6-sulfonate) radical cation (ABTS•+) by antioxidants to its original colorless ABTS form is the basis of the ABTS assay. The ABTS•+ is decolorized by antioxidants according to their antioxidant content [25]. A mixture of ABTS (10 mmol) and hydrogen peroxide (28.3 µmol) in acetic acid-sodium acetate buffer (30 mmol, pH 3.6, total volume of 2.0 mL) was quickly mixed with the plant species extract or a standard compound (100 µL) in a test tube. For positive referencing, Dibutyl hydroxytoluene (BHT) was used. The content of the tube was mixed and allowed to stand for 6 min and the absorbance was measured at 660 nm. Inhibition of free radical scavenging activity was calculated using the equation:

% Inhibition = 100 × (absorbance of the control − absorbance of the sample)/absorbance of the control

EC50 value (µg/mL) is the effective concentration at which ABTS•+ is scavenged by 50%. A calibration curve of ascorbic acid was established, the antioxidant content of the plant species extracts were then expressed as mmol ascorbic acid equivalent per gram of dry plant extract.

3.5.3. DPPH• Radical Assay

The DPPH stable radical scavenging capabilities of plant extract was determined according to a standard procedure reported by Nenandis et al. [25]. Methanolic solution of DPPH radical (3.8 mL, 60 µg/mL) was quickly mixed with the plant extract (200 µL) in a test tube. BHT was used as a positive standard. The contents of the tube were mixed and rested for 30 min. The absorbance was then measured at 517 nm. Inhibition of free radical scavenging activity was calculated using the equation:

% Inhibition = 100 × (absorbance of the control − absorbance of the sample)/absorbance of the control.

EC50 value (µg/mL) is the effective concentration at which DPPH• radicals are scavenged by 50%. A calibration curve of ascorbic acid was developed. The antioxidant content of the plant extracts were expressed as mmol ascorbic acid equivalent per gram of dry extract.

3.5.4. β-Carotene Bleaching Assay

The prevention of β-carotene bleaching by plant extracts was assessed according to the procedure of Lim et al. [16]. A sample of β-carotene solution (1.0 mL, 200 µg/mL in chloroform) was mixed with of linoleic acid (200 µL) and Tween 20 as emulsifier (200 µL). The mixture was evaporated to remove chloroform in a rotary evaporator at 40 °C. Deionized water (100 mL) was added slowly to form an emulsion. Portions of β-carotene/linoleic acid emulsion (3 mL each) were mixed in test tubes with 200 µL of various plant extract concentrations. The control was a 200 µL of 50% of methanol in 3.0 mL of the above emulsion. As a positive standard, BHT was used. After an incubation period of 120 minutes at 45 °C, the absorbance of the samples, standards and control were measured at 470 nm. Inhibition of free radical scavenging activity was calculated using the equation:

% Inhibition = 1 − (absorbance of the control at time zero − absorbance of the control after 120 min)/absorbance of the sample at time zero − absorbance of the sample 120 min) × 100

EC50 value (the effective concentration at which bleaching of β-carotene is prevented by 50% µg/mL) was determined graphically.

3.6. LOX Inhibitory Assay

Lipoxygenase (EC 1.13.11.12 type 1-B) (LOX) was assayed according to the method reported by Wu [26]. A mixture of a solution of sodium borate buffer (1 mL, 0.1 M, pH 8.8) and soybean LOX (10 µL, final conc. 8,000 U/mL) was incubated with plant species extract sample (10 µL) in a 1 mL cuvette at room temperature for 5 min. The reaction was initiated by the addition of linoleic acid substrate (10 µL, 10 mmol). The absorbance of the resulting mixture was measured at 234 nm over time at a rate of one measurement/min (3 readings). Inhibition of LOX was assessed using the following equation:

% Inhibition = 100 × (absorbance of the control − absorbance of the sample)/absorbance of the control)

The effective concentration (µg/mL) at which LOX activity is inhibited by 50% (IC50) was represented in a graph. Nordihydroguaiaretic acid (NDGA) was used as a positive standard.

3.7. HDAC Inhibition Activity Screening

HDAC inhibitory activity of Acridocarpus extracts was measured with HDAC Colorimetric Assay Kit (Millipore Corporation, Catalog number: 17-374). Plant extracts and trichostatin A, an inhibitor of HDAC, were mixed with Hela nuclear extract that contains a variety of HADC enzymes and has HDAC activity. HDAC colorimetric substrate was added to inhibitor and Hela nuclear extract mixture. A color is developed after a one hour treatment with the lysine developer. Absorbance at 405 was measured by micro plate reader model.

% Inhibition = 100 × (absorbance of the Hela nuclear extract − absorbance of the sample)/absorbance of the Hela nuclear extract)

The effective concentration (µg/mL) at which HDAC activity is inhibited by 50% (IC50) was determined graphically.

3.8. Statistical Analysis

Reported data are expressed as means ± SEM. Correlation analysis of antioxidants and the total phenolic content was conducted using SPSS (SPSS Inc., Chicago, IL, USA). When significant differences were detected, an analysis of differences between the means was performed by using Tukey’s HSD multiple comparison tests. Significance levels were set at p < 0.05.

4. Conclusions

The present biological investigation of Acridocarpus orientalis crude extracts demonstrated promising antioxidant, anti-LOX and anti-HDAC properties. Presumably, these biological activities could be attributed in part to the polyphenolic features of this plant species. This is absolutely the first published report on the biological properties of Acridocarpus orientalis growing in Al Ain and Oman. More in-vivo and in-vitro studies along with detailed phytochemical investigations are needed in order to potentially use this plant in the prevention and therapies of some oxidative damage related diseases. In short, the present study provides the biochemical foundation for further chemical analysis. Some animal as well as clinical studies are underway in our labs.

Acknowledgments

This research was partially supported by a grant from Shiakh Mohamed bin Zayed Species Conversation Fund (Project No. 21S031) and UAE University (Faculty of Science) Fund (Project No. 31S034). The investigators would like to express their sincere appreciation to Nael Mohamed Fawzi for his assistance in plant collection and identification. The collection of fresh samples from Nizwa region (Oman) by Fahad Khalifa Al Shidi is also appreciated.

Footnotes

Sample Availability: Not available.

References

  • 1.Williams R.J., Spencer J.P.E., Rice-Evans C. Flavonoids: Antioxidants or signalling molecules? Free Radic. Biol. Med. 2004;36:838–849. doi: 10.1016/j.freeradbiomed.2004.01.001. [DOI] [PubMed] [Google Scholar]
  • 2.Soobrattee M.A., Neergheen V.S., Luximon-Ramma A., Aruoma O., Bahorun T. Phenolics as potential antioxidant theraputic agents: Mechanism and actions. Mut. Res. 2005;579:200–213. doi: 10.1016/j.mrfmmm.2005.03.023. [DOI] [PubMed] [Google Scholar]
  • 3.Mitjavila M.T., Moreno J.J. The effects of polyphenols on oxidative stress and the arachidonic acid cascade: Implications for the prevention/treatment of high prevalence diseases. Biochem. Pharmacol. 2012;84:1113–1122. doi: 10.1016/j.bcp.2012.07.017. [DOI] [PubMed] [Google Scholar]
  • 4.Moreno J.J. New aspects of the role of hydroxyeicosatetraenoic acids in cell growth and cancer development. Biochem. Pharmacol. 2009;77:1–10. doi: 10.1016/j.bcp.2008.07.033. [DOI] [PubMed] [Google Scholar]
  • 5.Dobrian A.D., Lieb D.C., Cole B.K., Taylor-Fishwick D.A., Chakrabarti S.K., Nadler J.L. Functional and pathological roles of the 12- and 15-lipoxygenases. Prog. Lipid. Res. 2011;50:115–131. doi: 10.1016/j.plipres.2010.10.005. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 6.Pontiki E., Hadjipavlou-Litina H. Histone deacetylase inhibitors (HDACIs). Structure-activity relationships: History and new QSAR perspectives. Med. Res. Rev. 2012 doi: 10.1002/med.20200. [DOI] [PubMed] [Google Scholar]
  • 7.Mercurio C., Minucci S., Pelicci P.G. Histone deacetylases and epigenetic therapies of hematological malignancies. Pharmacol. Res. 2010;62:18–34. doi: 10.1016/j.phrs.2010.02.010. [DOI] [PubMed] [Google Scholar]
  • 8.Shah M.H., Binkley P., Chan K., Xiao J., Arbogast D., Collamore M., Farra Y., Young D., Grever M. Cardiotoxicity of histone deacetylase inhibitor depsipeptide in patients with metastatic neuroendocrine tumors. Clin. Cancer Res. 2006;12:3997–4003. doi: 10.1158/1078-0432.CCR-05-2689. [DOI] [PubMed] [Google Scholar]
  • 9.Walkinshaw D.R., Yang X.J. Histone deacetylase inhibitors as novel anticancer therapeutics. Curr.Oncol. 2008;15:237–243. [PMC free article] [PubMed] [Google Scholar]
  • 10.Kisksi T., Guenaoui C., Fawzi N. Early growth stages of the rare Acridocarpus orientalis in the UAE-A First step towards conservation. Nat. Resour. 2012;3:1–5. [Google Scholar]
  • 11.Monthana R.A., Lindequist U., Gruenert R., Bednarski P.J. Studies of the in vitro anticancer, antimicrobial and antioxidant potentials of selected Yemeni medicinal plants from the island Soqotra. BMC Complem. Altern. Med. 2009 doi: 10.1186/1472-6882-9-7. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 12.Hammiche V., Maiza K. Traditional medicine in central sahara:Pharmacopoeia of Tassili N’ajjer. J. Ethnopharmacol. 2006;105:358–367. doi: 10.1016/j.jep.2005.11.028. [DOI] [PubMed] [Google Scholar]
  • 13.Malebo H.M., Tanja W., Cal M., Swaleh S.A.M., Omolo M.O., Hassanali A., Séquin U., Hamburger M., Brun R., Ndiege I.O. Antiplasmodial, anti-trypanosomal, anti-leishmanial and cytotoxicity activity of selected Tanzanian medicinal plants. Tanzan. J. Health Res. 2009;11:226–234. doi: 10.4314/thrb.v11i4.50194. [DOI] [PubMed] [Google Scholar]
  • 14.Khasawneh M.A., Elwy H.M., Hamza A.A., Fawzi N.M., Hassan A.H. Antioxidant, anti-lipoxygenase and cytotoxic activity of Leptadenia pyrotechnica (Forssk.) decne polyphenolic constituents. Molecules. 2011;16:7510–7521. doi: 10.3390/molecules16097510. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 15.Yang J., Liu R.H., Halim L. Antioxidant and antiproliferative activities of common edible nut seeds. LWT-Food Sci. Technol. 2009;42:1–8. [Google Scholar]
  • 16.Lim Y.Y., Quah E.P.L. Antioxidant properties of different cultivars of Portulaca oleracea. Food Chem. 2007;103:734–740. doi: 10.1016/j.foodchem.2006.09.025. [DOI] [Google Scholar]
  • 17.Kosar M., Dorman H.J.D., Hiltunen R. Effect of an acid treatment on the phytochemical and antioxidant characteristics of extracts from selected Lamiaceae species. Food Chem. 2005;91:525–533. doi: 10.1016/j.foodchem.2004.06.029. [DOI] [Google Scholar]
  • 18.Conforti F., Sosa S., Marrelli M., Menichini F., Statti G.A., Uzunov D., Tubaro A., Menichini F., Loggia R.L. In vivo anti-inflammatory and in vitro antioxidant activities of mediterranean dietary plants. J. Ethnopharmacol. 2008;116:144–151. doi: 10.1016/j.jep.2007.11.015. [DOI] [PubMed] [Google Scholar]
  • 19.Conforti F., Sosa S., Marrelli M., Menichini F., Statti G.A., Uzunov D., Tubaro A., Menichini F. The protective ability of mediterranean dietary plants against the oxidative damage: The role of radical oxygen species in inflammation and the polyphenol, flavonoid and sterol contents. Food Chem. 2009;112:587–594. doi: 10.1016/j.foodchem.2008.06.013. [DOI] [Google Scholar]
  • 20.Wojdylo A., Oszmiański J., Czemerys R. Antioxidant activity and phenolic compounds in 32 selected herbs. Food Chem. 2007;105:940–949. doi: 10.1016/j.foodchem.2007.04.038. [DOI] [Google Scholar]
  • 21.Kumaraswamy M.V., Satish S. Antioxidant and anti-lipoxygenase activity of Thespesia lampas Dalz and Gibs. Advan. Biol. Res. 2008;2:56–59. [Google Scholar]
  • 22.Bora-Tatar G., Dayangac-Erden D., Demir A.S., Dalkara S., Yelekci K., Erdem-Yurter H. Molecular modifications on carboxylic acid derivatives as potent histone deacetylase inhibitors: Activity and docking studies. Bioorg. Med. Chem. 2009;17:5219–5228. doi: 10.1016/j.bmc.2009.05.042. [DOI] [PubMed] [Google Scholar]
  • 23.Rajendran P., Delage B., Dashwood W.M., Yu T.W., Wuth B., Williams D.E., Ho E., Dashwood R.H. Histone deacetylase turnover and recovery in sulforaphane-treated colon cancer cells: Competing actions of 14-3-3 and Pin1 in HDAC3/SMRT corepressor complex dissociation/reassembly. Mol. Cancer. 2011;10:1–18. doi: 10.1186/1476-4598-10-1. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 24.Singleton V.L., Orthofer R., Lamuela-raventos R.M. Analysis of total phenols and other oxidation substrates and antioxidants by means of folin-ciocalteu reagent. Meth. Enzymol. 1999;299:152–178. doi: 10.1016/S0076-6879(99)99017-1. [DOI] [Google Scholar]
  • 25.Nenadis N., Lazaridou O., Tsimidou M.Z. Use of reference compounds in antioxidant activity assessment. J. Agric. Food. Chem. 2007;55:5452–5460. doi: 10.1021/jf070473q. [DOI] [PubMed] [Google Scholar]
  • 26.Wu H. Affecting the activity of soybean lipoxygenase-1. J. mol. Graph. 1996;14:331–337. doi: 10.1016/S0263-7855(97)00006-4. [DOI] [PubMed] [Google Scholar]

Articles from Molecules are provided here courtesy of Multidisciplinary Digital Publishing Institute (MDPI)

RESOURCES